Little Known Facts About Glecaprevir.
Considering the fact that Pirfenidone is metabolised from the CYP1A2 enzyme pathway, any drug which inhibits this enzyme is likely to precipitate the toxicity of pirfenidone: concomitant therapy should be to be averted.Use of robust CYP1A2 inhibitors should be discontinued prior to initiating cure and averted in the course of cure; if potent CYP1A2